GlassScriptPhysician profile
Asna Shilleh
NPI 1174266589
$16,407.36
in general payments reported to CMS, 2019-2025
72 companies · $6,730 in 2025
The $6,730 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,524 · 2023: $2,083 · 2024: $5,070 · 2025: $6,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,892.92 |
| Education | $990.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $2,193.33 | 2022-2025 | Rybrevant, Carvykti, Erleada |
| Astrazeneca Pharmaceuticals LP | $1,265.63 | 2022-2025 | Calquence, Enhertu, Lynparza |
| Incyte Corporation | $1,006.62 | 2022-2025 | Jakafi, Niktimvo, Monjuvi |
| E.R. Squibb & Sons, L.L.C. | $947.26 | 2022-2025 | Opdivo, Breyanzi, Reblozyl |
| Celgene Corporation | $790.88 | 2022-2025 | Reblozyl, Pomalyst |
| Takeda Pharmaceuticals U.S.A., INC. | $785.62 | 2022-2025 | Fruzaqla, Iclusig, Ninlaro |
| Novartis Pharmaceuticals Corporation | $774.30 | 2022-2025 | |
| Daiichi Sankyo INC. | $600.52 | 2024-2025 | Enhertu, Datroway |
| Merck Sharp & Dohme LLC | $514.80 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Exelixis INC. | $499.54 | 2022-2025 | Cabometyx |
| Lilly USA, LLC | $493.23 | 2022-2025 | Verzenio, Retevmo, Jaypirca |
| Astellas Pharma US INC | $426.48 | 2023-2025 | Vyloy, Xospata, Xtandi |
| Pfizer INC. | $422.96 | 2022-2025 | |
| Genzyme Corporation | $346.18 | 2022-2025 | |
| Gilead Sciences, INC. | $333.97 | 2022-2025 | Trodelvy |
Show all 72 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Array Biopharma INC | $306.82 | 2022-2024 | Mektovi, Braftovi, Lorbrena |
| Seagen INC. | $301.00 | 2022 | |
| Genentech USA, INC. | $262.18 | 2022-2025 | Phesgo, Tecentriq Hybreza, Tecentriq |
| Emd Serono, INC. | $261.03 | 2022-2025 | |
| Karyopharm Therapeutics INC. | $256.90 | 2022-2025 | Xpovio |
| Abbvie INC. | $252.24 | 2023-2025 | |
| Tersera Therapeutics LLC | $242.79 | 2023-2025 | Zoladex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $228.82 | 2022-2025 | Gilotrif |
| Sobi, INC | $177.86 | 2023-2025 | |
| Puma Biotechnology, INC. | $164.93 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $158.48 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $141.03 | 2022-2025 | Onivyde, Somatuline Depot |
| Adc Therapeutics America, INC. | $138.80 | 2024-2025 | |
| Pharmaessentia USA Corporation | $132.36 | 2023-2025 | Besremi |
| Kyowa Kirin, INC. | $124.98 | 2023 | Poteligeo |
| Stemline Therapeutics INC. | $117.81 | 2025 | Orserdu |
| Aveo Pharmaceuticals, INC. | $115.65 | 2022-2025 | Fotivda |
| Taiho Oncology, INC. | $102.95 | 2022-2025 | |
| Eisai INC. | $85.97 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $82.24 | 2022-2024 | Yonsa |
| Alexion Pharmaceuticals, INC. | $81.96 | 2024-2025 | Ultomiris |
| Genmab U.S., INC. | $68.63 | 2024-2025 | Epkinly |
| Amgen INC. | $64.00 | 2023 | Kyprolis, Xgeva, Vectibix |
| Blueprint Medicines Corporation | $63.55 | 2024-2025 | Ayvakit |
| Deciphera Pharmaceuticals INC. | $62.99 | 2024-2025 | Qinlock |
| Dendreon Pharmaceuticals LLC | $62.86 | 2025 | Provenge |
| Morphosys, US INC. | $62.01 | 2022 | |
| Progenics Pharmaceuticals, INC. | $51.32 | 2025 | |
| Novocure INC. | $45.51 | 2024-2025 | Optune Lua (Novottf-200t) |
| Sumitomo Pharma America, INC. | $44.45 | 2025 | Orgovyx |
| Glaxosmithkline, LLC. | $41.56 | 2025 | Ojjaara |
| Bayer Healthcare Pharmaceuticals INC. | $41.26 | 2024 | |
| Coherus Oncology, INC. | $40.64 | 2022-2024 | |
| Tolmar Pharmaceuticals, INC. | $40.14 | 2022 | |
| Rigel Pharmaceuticals, INC. | $37.51 | 2024-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Syndax Pharmaceuticals, INC. | $34.91 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $33.63 | 2025 | Lynozyfic |
| Beigene USA, INC. | $33.55 | 2025 | Tevimbra |
| Acrotech Biopharma INC. | $33.31 | 2024 | Beleodaq |
| Agios Pharmaceuticals, INC. | $29.79 | 2024 | Pyrukynd |
| Springworks Therapeutics, INC. | $29.57 | 2025 | Ogsiveo |
| Beone Medicines USA, INC. | $28.32 | 2025 | Tevimbra |
| Immunocore Limited | $27.97 | 2024 | Kimmtrak |
| Caris Mpi, INC. | $27.54 | 2025 | Mi Cancer Seek |
| Octapharma USA, INC. | $27.34 | 2025 | Panzyga |
| Tolmar, INC. | $25.39 | 2023 | |
| G1 Therapeutics, INC. | $24.70 | 2022 | |
| Accord Healthcare, INC. | $23.49 | 2024 | |
| Ge Healthcare | $22.73 | 2024 | |
| Pharmacosmos Therapeutics INC. | $22.17 | 2022 | |
| Shorla Oncology INC. | $22.15 | 2025 | |
| Immunogen, INC. | $21.56 | 2024 | Elahere |
| Chiesi USA, INC. | $16.85 | 2025 | Ferriprox |
| Adaptive Biotechnologies Corporation | $16.82 | 2024 | Clonoseq |
| Cumberland Pharmaceuticals, INC. | $14.63 | 2024 | Sancuso |
| Alnylam Pharmaceuticals INC. | $13.94 | 2022 | |
| Emmaus Medical, INC. | $12.45 | 2024 | Endari |
Drugs and devices associated with these payments
Rybrevant $750Carvykti $749Enhertu $738Erleada $730Reblozyl $710Jakafi $475Tecvayli $441Opdivo $436Keytruda $421Calquence $421Darzalex $366Verzenio $319Fruzaqla $310Cabometyx $277Lynparza $256Balversa $251Akeega $251Breyanzi $246Zoladex $243Mektovi $233Braftovi $233Talvey $232Epkinly $211Retevmo $194Sarclisa $190Jaypirca $183Scemblix $176Fabhalta $169Lorbrena $165Xalkori $165Doptelet $155Kisqali $151Iclusig $150Padcev $144Imbruvica $143Niktimvo $136Besremi $132Xpovio $125Poteligeo $125Tukysa $118Orserdu $118Xtandi $118Onivyde $117Somatuline Depot $117Cyramza $113Zepzelca $102Trodelvy $98.74Ayvakit $93.18Orgovyx $91.12Ibrance $90.94Tabrecta $85.58Venclexta $84.23Fotivda $82.72Imfinzi $81.98Ultomiris $81.96Inqovi $78.89Lonsurf $78.89Vyloy $77.71Gilotrif $77.34Monjuvi $76.39Tivdak $69.16Tecentriq Hybreza $66.51Phesgo $66.51Lenvima $63.63Qinlock $62.99Provenge $62.86Nerlynx $62.66Tevimbra $61.87Tecentriq $58.94Ziihera $56.82Ninlaro $55.94Xospata $55.84Datroway $55.47Pluvicto $54.48Welireg $53.43Pemazyre $52.64Pylarify $51.32Elahere $49.39Polivy $48.71Yonsa $47.60Talzenna $46.67Zynlonta $45.53Optune Lua (Novottf-200t) $45.51Pomalyst $44.28Tagrisso $44.01Wayrilz $43.58Ojjaara $41.56Itovebi $37.73Tavalisse $37.51Rezlidhia $37.51Lynozyfic $33.63Beleodaq $33.31Pyrukynd $29.79Ogsiveo $29.57Odomzo $28.15Kimmtrak $27.97Mi Cancer Seek $27.54Panzyga $27.34Kyprolis $26.66Eligard $25.39
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asna Shilleh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.